Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.24654 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.17092 | 49 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.1735 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.05943 | 47 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.11188 | 49 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.3257 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.29169 | 50 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.17711 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.1403 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.16111 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.17094 | 49 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.10161 | 48 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.17725 | 49 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.17028 | 49 |